Literature DB >> 17301080

Upregulation of opioid receptor binding following spontaneous epileptic seizures.

Alexander Hammers1, Marie-Claude Asselin, Rainer Hinz, Ian Kitchen, David J Brooks, John S Duncan, Matthias J Koepp.   

Abstract

Animal and limited human data suggest an important anticonvulsant role for opioid peptides and their receptors. We aimed to provide direct human in vivo evidence for changes in opioid receptor availability following spontaneous seizures. We scanned nine patients within hours of spontaneous temporal lobe seizures and compared their postictal binding of the non-subtype selective opioid receptor PET radioligand [11C]diprenorphine (DPN), quantified as a volume-of-distribution (VD), with interictal binding and with binding changes in 14 healthy controls, controlling for a range of behavioural variables associated with opioid action. A regionally specific increase of opioid receptor availability was evident in the temporal pole and fusiform gyrus ipsilateral to the seizure focus following seizures (Z 5.01, P < 0.001, 16 432 mm3). Within this region, there was a negative correlation between VD and log10 time since last seizure (r = -0.53, P < 0.03), compatible with an early increase and gradual return to baseline. [11C]DPN VD did not undergo systematic changes between time points in controls. This study provides direct human in vivo evidence for changes in opioid receptor availability over a time course of hours following spontaneous seizures, emphasizing an important role of the opioid system in seizure control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301080     DOI: 10.1093/brain/awm012

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  27 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 2.  The postictal state: effects of age and underlying brain dysfunction.

Authors:  William H Theodore
Journal:  Epilepsy Behav       Date:  2010-08-17       Impact factor: 2.937

3.  PET imaging in pediatric neuroradiology: current and future applications.

Authors:  Sunhee Kim; Noriko Salamon; Hollie A Jackson; Stefan Blüml; Ashok Panigrahy
Journal:  Pediatr Radiol       Date:  2009-11-24

Review 4.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

5.  Epileptiform synchronization in the cingulate cortex.

Authors:  Gabriella Panuccio; Giulia Curia; Alfredo Colosimo; Giorgio Cruccu; Massimo Avoli
Journal:  Epilepsia       Date:  2008-10-30       Impact factor: 5.864

Review 6.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

7.  Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study.

Authors:  A Lothe; A Didelot; A Hammers; N Costes; M Saoud; F Gilliam; P Ryvlin
Journal:  Brain       Date:  2008-09-02       Impact factor: 13.501

Review 8.  From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy.

Authors:  George B Richerson; Detlev Boison; Carl L Faingold; Philippe Ryvlin
Journal:  Epilepsia       Date:  2016-01       Impact factor: 5.864

9.  Evidence for modulation of opioidergic activity in central vestibular processing: A [(18)F] diprenorphine PET study.

Authors:  Bernhard Baier; Sandra Bense; Frank Birklein; Hans-Georg Buchholz; Anja Mischke; Matthias Schreckenberger; Marianne Dieterich
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

10.  Sleep deprivation increases cerebral serotonin 2A receptor binding in humans.

Authors:  David Elmenhorst; Tina Kroll; Andreas Matusch; Andreas Bauer
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.